137 related articles for article (PubMed ID: 24911300)
1. Beta-blockers and depression in elderly hypertension patients in primary care.
Ringoir L; Pedersen SS; Widdershoven JW; Pouwer F; Keyzer JM; Romeijnders AC; Pop VJ
Fam Med; 2014 Jun; 46(6):447-53. PubMed ID: 24911300
[TBL] [Abstract][Full Text] [Related]
2. Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study.
Wong MC; Jiang JY; Griffiths SM
Clin Ther; 2009 Oct; 31(10):2170-7; discussion 2150-1. PubMed ID: 19922888
[TBL] [Abstract][Full Text] [Related]
3. Beta-blockers and depression after myocardial infarction: a multicenter prospective study.
van Melle JP; Verbeek DE; van den Berg MP; Ormel J; van der Linde MR; de Jonge P
J Am Coll Cardiol; 2006 Dec; 48(11):2209-14. PubMed ID: 17161247
[TBL] [Abstract][Full Text] [Related]
4. [Lipophilic beta blockers cause an increase in depression in primary care patients].
Zechmann S
Praxis (Bern 1994); 2015 Aug; 104(16):869-70. PubMed ID: 26242424
[No Abstract] [Full Text] [Related]
5. Use of beta-blockers for uncomplicated hypertension in the elderly: a cause for concern.
Tu K; Campbell NR; Chen Z; McAlister FA
J Hum Hypertens; 2007 Apr; 21(4):271-5. PubMed ID: 17287848
[TBL] [Abstract][Full Text] [Related]
6. Identifying iatrogenic depression using confirmatory factor analysis of the Center for Epidemiologic Studies Depression Scale in patients prescribed a verapamil-sustained-release-led or atenolol-led hypertension treatment strategy.
Wilson DL; Ried LD
Res Social Adm Pharm; 2012; 8(4):309-20. PubMed ID: 22133650
[TBL] [Abstract][Full Text] [Related]
7. Hypertension treatment and outcomes in US nursing homes: results from the US National Nursing Home Survey.
Simonson W; Han LF; Davidson HE
J Am Med Dir Assoc; 2011 Jan; 12(1):44-9. PubMed ID: 21194659
[TBL] [Abstract][Full Text] [Related]
8. Beta-blockers are associated with increased risk of first cardiovascular events in non-diabetic hypertensive elderly patients.
Brouwers FM; Courteau J; Cohen AA; Farand P; Cloutier L; Asghari S; Vanasse A
Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1139-46. PubMed ID: 25045055
[TBL] [Abstract][Full Text] [Related]
9. Metabolic sequelae of β-blocker therapy: weighing in on the obesity epidemic?
Lee P; Kengne AP; Greenfield JR; Day RO; Chalmers J; Ho KK
Int J Obes (Lond); 2011 Nov; 35(11):1395-403. PubMed ID: 21304487
[TBL] [Abstract][Full Text] [Related]
10. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study.
Liou YS; Ma T; Tien L; Lin CM; Jong GP
Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541
[TBL] [Abstract][Full Text] [Related]
11. Nebivolol: a third-generation beta-blocker for hypertension.
Cheng JW
Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial.
Ogihara T; Matsuzaki M; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T;
Hypertens Res; 2012 Apr; 35(4):441-8. PubMed ID: 22278623
[TBL] [Abstract][Full Text] [Related]
13. Increased prescribing of antidepressants subsequent to beta-blocker therapy.
Thiessen BQ; Wallace SM; Blackburn JL; Wilson TW; Bergman U
Arch Intern Med; 1990 Nov; 150(11):2286-90. PubMed ID: 1978648
[TBL] [Abstract][Full Text] [Related]
14. Discontinuation of beta-blockers and the risk of myocardial infarction in the elderly.
Teichert M; de Smet PA; Hofman A; Witteman JC; Stricker BH
Drug Saf; 2007; 30(6):541-9. PubMed ID: 17536880
[TBL] [Abstract][Full Text] [Related]
15. Smoking, antihypertensive treatment benefit, and comprehensive antihypertensive treatment approach: some thoughts on the results of the International Prospective Primary Prevention Study in Hypertension.
Bolli P; Bühler FR; McKenzie JK
J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S77-80. PubMed ID: 1708033
[TBL] [Abstract][Full Text] [Related]
16. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
Baumgart P; Reismann J; Pohlmeyer H; Düsing R
Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910
[TBL] [Abstract][Full Text] [Related]
17. β1 selectivity of β-blockers and reduced risk of fractures in elderly hypertension patients.
Song HJ; Lee J; Kim YJ; Jung SY; Kim HJ; Choi NK; Park BJ
Bone; 2012 Dec; 51(6):1008-15. PubMed ID: 22960238
[TBL] [Abstract][Full Text] [Related]
18. Treating hypertension. Are the right drugs given to the right patients?
Beaulieu MD; Dufresne L; LeBlanc D
Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
[TBL] [Abstract][Full Text] [Related]
19. Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents.
Cordero A; Bertomeu-Martínez V; Mazón P; Fácila L; Bertomeu-González V; Conthe P; González-Juanatey JR
Cardiovasc Ther; 2010; 28(1):15-22. PubMed ID: 20074255
[TBL] [Abstract][Full Text] [Related]
20. Challenges for beta-blockers as first-line therapy for elderly hypertensive patients.
Prisant LM
Postgrad Med; 2002 Dec; 112(6 Suppl Heart):34-41. PubMed ID: 19667616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
